Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A growing medtech role in NHS copayment reforms?

This article was originally published in Clinica

Executive Summary

UK plans unveiled yesterday to expand access to NHS treatments and to allow private treatment to run in parallel to NHS care, enabling patients to have an active role in embracing innovative – and potentially more costly – treatments, should increasingly impinge on access to innovative medical technology too. So suggests the UK-based pan-regional lobby association, the Medical Technology Group (MTG), in recommendations submitted to the House of Commons health select committee (HSC), as part of an inquiry into patient safety*.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042269

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel